Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL
NCT03407859
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Therapy Related Leukemia
Interventions
BIOLOGICAL:
Sequential Treatment With different CART
Sponsor
Zhujiang Hospital
Collaborators
[object Object]